News & Articles

Both vaccines are highly effective and either one is strongly recommended

Discover insights on topics from lab automation and gene therapy to monoclonal antibodies and clinical diagnostics

Explore the latest research in biopharma from scientific posters presented at the SelectScience Virtual Biopharma Summit 2021

Discover insights on topics from cell line development and cancer research, to preparative HPLC and COVID-19 testing

New preclinical data further supports ability of CM-101 to break the vicious cycle of inflammation and fibrosis in primary sclerosing cholangitis

Discover how Merck KGaA, Darmstadt, Germany is helping to combine scientific innovation and environmental stewardship

Top talks from world-leading scientists and the latest resources in the field are now available on demand

Associate Professor Allan Stensballe discusses the use of autoantibodies in precision medicine and the protein microarray technology enabling his research

We hear from Kevin Entzminger on how Abwiz Bio is developing next-gen antibody therapeutics to help answer fundamental questions in science

Which new products helped to accelerate your lab work this year?

The panels complete Bio-Rad’s set of Bio-Plex™ Pro Multiplex SARS-CoV-2 Human Serology Panels for detection of antibodies against four SARS-CoV-2 antigens

Gain insights on topics from antibody performance and cell line development to food safety method validation and more

Measurement of anti-S1/RBD antibodies, neutralizing antibodies targeting S1/RBD, and specific T-cells using EUROIMMUN tests supports evaluation of the immune reaction to SARS-CoV-2 following vaccination or infection

Introduced at AACC, the VeraPrep Antibody Detection Kit enables researchers to measure antibodies against any antigen of interest in serum, plasma or saliva

Two new studies reveal how antibodies against the SARS-CoV-2 virus can vary between individuals

The partnership will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test which will shortly begin clinical trials for FDA EUA market clearance

The latest discoveries show potential in resolving persistent challenges in healthcare and lab testing for women

Chemomab’s CM-101 is a first-in-class, CCL24-neutralizing monoclonal antibody expected to enter a Phase 2 clinical trial in SSc patients early next year

Watch world-leading scientists online, October 5, to discover the latest tools and techniques advancing Alzheimer's research, single cell characterization, biomarker discovery and more

The three new respiratory test panels on cobas 6800/8800 Systems in CE markets will help identify multiple pathogens with overlapping symptoms in patients